IL-6 , IL-8 and IL-10 polymorphisms may impact predisposition of Alzheimer’s disease: a meta-analysis

Gene polymorphisms in interleukin-6 ( IL-6 ), interleukin-8 ( IL-8 ), and interleukin-10 (IL-10 ) may affect the predisposition of Alzheimer’s disease (AD), but the results of the so far published studies remain controversial. The authors conducted this meta-analysis to assess relationships between IL-6/IL-8/IL-10 polymorphisms and predisposition of AD by pooling the findings of so far published studies. A comprehensive search of Pubmed, Embase, Web of Science, and CNKI was endorsed by the authors to identify the already published studies. Forty-five studies were found to be eligible for meta-analyses. The pooled meta-analyses results showed that genotypic frequencies of IL-6 − 174 G/C, IL-6 − 572 G/C and IL-10 − 1082 A/G polymorphisms among patients with AD and controls differed significantly. Moreover, genotypic frequencies of IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-8 − 251 A/T polymorphisms among patients with AD and controls in Asians also differed significantly. But no such genotypic frequencies’ differences were observed for IL-10 − 819 C/T and 592 C/A polymorphisms. This meta-analysis suggests that IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-10 − 1082 A/G polymorphisms may affect the predisposition of AD in overall population. Moreover, IL-6 − 174 G/C, IL-6 − 572 G/C, and IL-8 − 251 A/T polymorphisms may affect the predisposition of AD in Asians.